Zenas BioPharma, Inc. (ZBIO)
38.18
-1.19
(-3.02%)
USD |
NASDAQ |
Dec 09, 16:00
38.17
0.00 (0.00%)
Pre-Market: 09:26
Zenas BioPharma Cash from Investing (Quarterly): 40.04M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Royalty Pharma Plc | -959.42M |
| Amgen, Inc. | -414.00M |
| Nektar Therapeutics | -94.87M |
| Rigel Pharmaceuticals, Inc. | -33.18M |
| Aquestive Therapeutics, Inc. | -0.235M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.12M |
| Cash from Financing (Quarterly) | 72.62M |
| Free Cash Flow | -158.56M |
| Free Cash Flow Per Share (Quarterly) | -0.9755 |
| Free Cash Flow to Equity (Quarterly) | -40.92M |
| Free Cash Flow to Firm (Quarterly) | -41.12M |
| Free Cash Flow Yield | -9.91% |